Increased survival and reduced renal injury in MRL/lpr mice treated with a human Fcγ receptor II (CD32) peptide.
Xi J, Zhang GP, Qiao SL, Guo JQ, Wang XN, Yang YY, Zhang LN, Miao XW, Zhao D, Zhi YB, Cai SJ, Luo J, Deng RG.
Xi J, et al. Among authors: zhang gp, zhang ln.
Immunology. 2012 May;136(1):46-53. doi: 10.1111/j.1365-2567.2012.03553.x.
Immunology. 2012.
PMID: 22236212
Free PMC article.